Comprehensive Efficacy of the Dipeptidyl Peptidase 4 Inhibitor Alogliptin in Practical Clinical Settings: A Prospective Multi-Center Interventional Observational Study

BACKGROUND: This study aimed to verify the safety and efficacy, including glycemic control, of the selective dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes. METHODS: This study used a multi-center, open-label, prospective observational design. Type 2 diabetes patients w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med Res
Autors principals: Takamiya, Yosuke, Kobayashi, Kunihisa, Kudo, Tadachika, Okuda, Tetsu, Okamura, Keisuke, Shirai, Kazuyuki, Urata, Hidenori
Format: Artigo
Idioma:Inglês
Publicat: Elmer Press 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331869/
https://ncbi.nlm.nih.gov/pubmed/32655736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr4224
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars